Correlation Between Mangalam Drugs and Nucleus Software
Specify exactly 2 symbols:
By analyzing existing cross correlation between Mangalam Drugs And and Nucleus Software Exports, you can compare the effects of market volatilities on Mangalam Drugs and Nucleus Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Nucleus Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Nucleus Software.
Diversification Opportunities for Mangalam Drugs and Nucleus Software
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Mangalam and Nucleus is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Nucleus Software Exports in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nucleus Software Exports and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Nucleus Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nucleus Software Exports has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Nucleus Software go up and down completely randomly.
Pair Corralation between Mangalam Drugs and Nucleus Software
Assuming the 90 days trading horizon Mangalam Drugs And is expected to generate 1.59 times more return on investment than Nucleus Software. However, Mangalam Drugs is 1.59 times more volatile than Nucleus Software Exports. It trades about -0.03 of its potential returns per unit of risk. Nucleus Software Exports is currently generating about -0.22 per unit of risk. If you would invest 13,225 in Mangalam Drugs And on September 2, 2024 and sell it today you would lose (1,012) from holding Mangalam Drugs And or give up 7.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mangalam Drugs And vs. Nucleus Software Exports
Performance |
| Timeline |
| Mangalam Drugs And |
| Nucleus Software Exports |
Mangalam Drugs and Nucleus Software Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mangalam Drugs and Nucleus Software
The main advantage of trading using opposite Mangalam Drugs and Nucleus Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Nucleus Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nucleus Software will offset losses from the drop in Nucleus Software's long position.| Mangalam Drugs vs. MRF Limited | Mangalam Drugs vs. Bosch Limited | Mangalam Drugs vs. Bajaj Holdings Investment | Mangalam Drugs vs. Vardhman Holdings Limited |
| Nucleus Software vs. Ankit Metal Power | Nucleus Software vs. Nahar Industrial Enterprises | Nucleus Software vs. Kewal Kiran Clothing | Nucleus Software vs. Newgen Software Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |